Latest market price
13.40
-0.24-1.76%
TA
Loading chart...
Snapshot
| Index | — | P/E | 103.08 | EPS (ttm) | 0.13 | Insider Own | — | Shs Outstand | 382.15M | Perf Week | 3.63% |
| Market Cap | 5.12B | Forward P/E | 61.07 | EPS next Y | 0.22 | Insider Trans | -11.57% | Shs Float | 200.06M | Perf Month | 12.51% |
| Enterprise Value | 5.10B | PEG | 1.59 | EPS next Q | 0.04 | Short Float | 6.88% | Perf Quarter | 27.13% | ||
| Income | 51.00M | P/S | 3.23 | EPS this Y | — | Short Ratio | 3.22 | Perf Half Y | 77.95% | ||
| Sales | 1.58B | P/B | 3.47 | EPS next Y | 35.28% | ROA | 2.32% | Short Interest | 13.77M | Perf YTD | 90.34% |
| Book/sh | 3.86 | P/C | 22.66 | EPS next 5Y | 64.96% | ROE | 3.39% | 52W High | 13.76 -2.62% | Perf Year | 169.08% |
| Cash/sh | 0.59 | P/FCF | 24.39 | EPS past 3/5Y | — | ROIC | 3.03% | 52W Low | 4.77 180.92% | Perf 3Y | 142.75% |
| Dividend Est. | — | EV/EBITDA | 38.61 | Sales past 3/5Y | 18.31% 30.45% | Gross Margin | 33.56% | Volatility | 3.16% 3.35% | Perf 5Y | 22.49% |
| Dividend TTM | — | EV/Sales | 3.22 | EPS Y/Y TTM | — | Oper. Margin | 4.95% | ATR (14) | 0.43 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 1.38 | Sales Y/Y TTM | 20.36% | Profit Margin | 3.19% | RSI (14) | 64.76 | Recom | 2.18 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.38 | EPS Q/Q | — | SMA20 | 6.88% | Beta | 1.33 | Target Price | 14.14 |
| Payout | 0.00% | Debt/Eq | 0.14 | Sales Q/Q | 26.09% | SMA50 | 7.36% | Rel Volume | 0.52 | Prev Close | 13.64 |
| Employees | 8,542 | LT Debt/Eq | 0.10 | Earnings | Nov 05 | SMA200 | 43.51% | Avg Volume | 4.42M | Price | 13.40 |
| IPO Date | Jun 10, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 83.21% 5.01% | Net Debt/EBITDA | -0.19 | Volume | 2,298,631 | Change | -1.76% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-05-26 | Reiterated | Keybanc | Overweight | $13 → $15 |
| Sep-10-26 | Reiterated | Barclays | Overweight | $13 → $15 |
| Sep-09-26 | Reiterated | Canaccord Genuity | Buy | $13 → $15 |
| Aug-19-26 | Reiterated | BTIG | Buy | $16 → $19 |
| Aug-07-26 | Reiterated | Morgan Stanley | Overweight | $10 → $13 |
| Aug-07-26 | Reiterated | BMO Capital | $10 → $13 | |
| Aug-07-26 | Reiterated | BTIG | Buy | $15 → $16 |
| Jul-24-26 | Reiterated | BTIG | Buy | $11 → $15 |
| Jul-21-26 | Reiterated | Canaccord Genuity | Buy | $11 → $13 |
| Jul-14-26 | Reiterated | Barclays | Overweight | $8.00 → $13 |
Latest News· Times ET
Oct-29-26
Oct-29-2609:00AM
Oct-26-26
Oct-20-26
Oct-15-26
Oct-15-2604:10PM
Oct-12-26
Oct-12-2611:11AM
Oct-06-26
Oct-05-26
Oct-05-2604:21AM
Sep-30-26
Sep-30-2609:00AM
Sep-23-26
Sep-18-26
Sep-16-26
Sep-16-2604:37AM
Sep-15-26
Sep-15-2612:21PM
Sep-11-26
Sep-11-2604:06AM
03:45AM
Sep-10-26
Company
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,584 | 1,424 | 1,251 | 1,056 | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,053 | 963 | 849 | 754 | — | — | — | — | |
| Gross Profit | 532 | 461 | 402 | 302 | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 399 | 382 | 363 | 411 | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | |
| Other Operating Expense | 54 | 55 | 71 | 80 | — | — | — | — | |
| Operating Income | 78 | 24 | -32 | -189 | — | — | — | — | |
| Interest Expense | 11 | 12 | 27 | 21 | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -2 | 0 | 1 | 4 | — | — | — | — | |
| Net Income Before Taxes | 67 | 12 | -58 | -207 | — | — | — | — | |
| Income Taxes | 17 | 3 | 0 | -20 | — | — | — | — | |
| Consolidated Net Income | 51 | 10 | -57 | -186 | — | — | — | — | |
| Net Income From Continuing Operations | 51 | 10 | -57 | -186 | — | — | — | — | |
| Net Income | 51 | 10 | -57 | -186 | — | — | — | — | |
| EPS (Recurring) | 0.13 | 0.03 | -0.15 | -0.51 | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.13 | 0.03 | -0.15 | -0.51 | — | — | — | — | |
| EPS (Diluted) | 0.13 | 0.02 | -0.15 | -0.51 | — | — | — | — | |
| EBITDA | 132 | 79 | 40 | -105 | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 103.08 | 352.00 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.25 | 1.91 | 2.23 | 2.72 | — | — | — | — | |
| Gross Margin | 33.59 | 32.37 | 32.13 | 28.60 | — | — | — | — | |
| Operating Margin | 4.92 | 1.69 | -2.56 | -17.90 | — | — | — | — | |
| Net Margin | 3.22 | 0.70 | -4.56 | -17.61 | — | — | — | — | |
| Shares Outstanding | 384 | 386 | 379 | 367 | — | — | — | — | |
| Market Capitalization | 5,146 | 2,717 | 2,793 | 2,874 | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 10% Owner | Sep 11 '26 | Sale | 12.29 | 18,409,705 | 226,255,274 | 79,691,702 | Sep 15 |
| Paunovich Vukasin | Chief Technology Officer | Sep 02 '26 | Sale | 12.87 | 42,067 | 541,402 | 205,379 | Sep 04 |
| DeLuca Teresa | Director | Aug 14 '26 | Sale | 12.68 | 7,500 | 95,100 | 97,093 | Aug 18 |
| DeLuca Teresa | Director | Aug 13 '26 | Sale | 12.23 | 20,441 | 249,993 | 104,593 | Aug 14 |
| Burdick Kenneth A | Director | Aug 11 '26 | Sale | 11.51 | 500,000 | 5,755,000 | 2,970,810 | Aug 13 |
| Paunovich Vukasin | Chief Technology Officer | Aug 10 '26 | Sale | 10.85 | 44,394 | 481,675 | 247,446 | Aug 12 |
| TPG GP A, LLC | 10% Owner | Aug 10 '26 | Sale | 10.62 | 13,643,207 | 144,890,858 | 98,101,407 | Aug 12 |
| Miller Lisa K | Chief Operating Officer | Aug 10 '26 | Sale | 10.85 | 47,912 | 519,845 | 281,289 | Aug 12 |
| Bessler Robert | Director | Jun 26 '26 | Sale | 10.13 | 894,337 | 9,059,634 | 539,763 | Jun 30 |
| Shuey Eric | Director | May 12 '26 | Sale | 8.02 | 243,362 | 1,951,763 | 867,562 | May 14 |
| BLACK DARREN M. | Director | May 12 '26 | Sale | 8.02 | 5,899,661 | 47,315,281 | 23,310,115 | May 14 |
| TPG GP A, LLC | 10% Owner | May 12 '26 | Sale | 8.02 | 28,281,943 | 226,821,183 | 111,744,614 | May 14 |
| Bessler Robert | Director | May 12 '26 | Sale | 8.02 | 575,034 | 4,611,772 | 986,931 | May 14 |
| Bessler Robert | Director | May 07 '26 | Sale | 8.55 | 75,000 | 641,250 | 1,236,948 | May 11 |
| Bessler Robert | Director | Apr 24 '26 | Sale | 7.05 | 62,147 | 438,137 | 1,274,448 | Apr 27 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.